Quarterly report pursuant to Section 13 or 15(d)

STOCKHOLDERS' EQUITY (DEFICIT) (Details)

v3.19.3.a.u2
STOCKHOLDERS' EQUITY (DEFICIT) (Details)
9 Months Ended
Dec. 31, 2019
$ / shares
shares
Warrants outstanding 36
Warrant - Exercise Price 195,412.50 [Member]  
Warrants outstanding 3 [1]
Warrant exercise price | $ / shares $ 195,412.50
Warrant Expiration date Sep. 12, 2022
Warrant - Exercise Price 12,187.50 [Member]  
Warrants outstanding 32 [2]
Warrant exercise price | $ / shares $ 12,187.50
Warrant Expiration date May 24, 2023
Warrant - Exercise Price 1,171,875.00 [Member]  
Warrants outstanding 1 [3]
Warrant exercise price | $ / shares $ 1,171,875.00
Warrant Expiration date Apr. 26, 2021
[1] Warrants issued in connection with the Initial Tranche of the funding from Vantage. The warrants were exercisable on the grant date (September 12, 2017) and remain exercisable until September 12, 2022.
[2] Warrants issued in connection with the Severance Agreement with Richard N. Azar II. The warrants were exercisable on the grant date (May 25, 2018) and remain exercisable until May 24, 2023.
[3] Warrants issued in connection with the sale of convertible notes. The warrants were exercisable on the grant date (April 26, 2016) and remain exercisable until April 26, 2021.